A multicenter study: New cut‐off values of antitransglutaminase antibodies processed by chemiluminescence in children with suspected celiac disease
We suggest that the use of 30 times the NV cutoff values would be the best predictor of which patients do not need a biopsy.
Authors
- Verónica Busoni (ORCID: https://orcid.org/0000-0003-3015-0598)
- Mabel Mora
- María del Carmen Toca (ORCID: https://orcid.org/0000-0002-5589-1213)
- Florencia Ursino
- Marina Orsi (ORCID: https://orcid.org/0000-0001-6190-0254)
- Román Bigliardi (ORCID: https://orcid.org/0000-0001-6316-5513)
- Gabriela Messere (ORCID: https://orcid.org/0009-0004-7756-037X)
- Gonzalo Ortiz (ORCID: https://orcid.org/0000-0002-0289-6192)
- Fernando Battiston
- Rosana Solis Neffa
Institutions
- Hospital Italiano de Buenos Aires (AR)
- Hospital Materno-Infantil (ES)
- Hospital Posadas (AR)
Publication Details
- Journal
- JPGN Reports
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1002/jpr3.12169
- Citations
- 4
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 7.24